Cargando…
Pseudomonas aeruginosa: Recent Advances in Vaccine Development
Pseudomonas aeruginosa is an important opportunistic human pathogen. Using its arsenal of virulence factors and its intrinsic ability to adapt to new environments, P. aeruginosa causes a range of complicated acute and chronic infections in immunocompromised individuals. Of particular importance are...
Autores principales: | Killough, Matthew, Rodgers, Aoife Maria, Ingram, Rebecca Jo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320790/ https://www.ncbi.nlm.nih.gov/pubmed/35891262 http://dx.doi.org/10.3390/vaccines10071100 |
Ejemplares similares
-
Recent advances in understanding
Pseudomonas aeruginosa as a pathogen
por: Klockgether, Jens, et al.
Publicado: (2017) -
Recent Advance in Small Molecules Targeting RhlR of Pseudomonas aeruginosa
por: Lim, Taehyeong, et al.
Publicado: (2022) -
Recent advances in therapeutic targets identification and development of treatment strategies towards Pseudomonas aeruginosa infections
por: Sanya, Daniel Ruben Akiola, et al.
Publicado: (2023) -
Biologically Relevant Murine Models of Chronic Pseudomonas aeruginosa Respiratory Infection
por: Rodgers, Aoife M., et al.
Publicado: (2023) -
Recent advancements in the production of rhamnolipid biosurfactants by Pseudomonas aeruginosa
por: Eslami, Parisa, et al.
Publicado: (2020)